InnovationRx: Two Industry Veterans Aim To Accelerate The Path To Personalized Care

  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 14 sec. here
  • 10 min. at publisher
  • 📊 Quality Score:
  • News: 37%
  • Publisher: 59%

Ai ニュース

Artificial Intelligence,Patrick Soon-Shiong,Covid

Alex Knapp is a senior editor covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.

to learn more about the effectiveness of different types of treatments.. “And we see that one of the critical gates on that path is in clinical evidence generation.”

But there is one catch: right now, creating these cells into useful tissues is a laborious process that can cost hundreds of thousands, if not millions, of dollars per patient. This makes both research and the development of potential cures an expensive prospect.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 318. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し